About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Map9tm1.1Bcgen
targeted mutation 1.1, Biocytogen LLC
MGI:6502641
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Map9tm1.1Bcgen/Map9tm1.1Bcgen
Tg(CDX2-cre/ERT2)752Erf/0
involves: 129S4/SvJaeSor * C57BL/6J * SJL/J MGI:6502655
cn2
Map9tm1.1Bcgen/Map9+
Tg(CDX2-cre/ERT2)752Erf/0
involves: 129S4/SvJaeSor * C57BL/6J * SJL/J MGI:6502656


Genotype
MGI:6502655
cn1
Allelic
Composition
Map9tm1.1Bcgen/Map9tm1.1Bcgen
Tg(CDX2-cre/ERT2)752Erf/0
Genetic
Background
involves: 129S4/SvJaeSor * C57BL/6J * SJL/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Map9tm1.1Bcgen mutation (0 available); any Map9 mutation (27 available)
Tg(CDX2-cre/ERT2)752Erf mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• 22.7% of mice injected with tamoxifen develop colonic dysplasia at 15 months post injection
• 9.1% of mice develop colon cancer at 15 months post injection with tamoxifen

homeostasis/metabolism
• mice treated with colonic carcinogen azoxymethane (AOM) show higher tumor incidence (100%) compared to treated wild-type mice (67%) and have an increase in tumor number and burden compared with controls

neoplasm
• 9.1% of mice develop colon cancer at 15 months post injection with tamoxifen
• mice treated with colonic carcinogen azoxymethane (AOM) show higher tumor incidence (100%) compared to treated wild-type mice (67%) and have an increase in tumor number and burden compared with controls




Genotype
MGI:6502656
cn2
Allelic
Composition
Map9tm1.1Bcgen/Map9+
Tg(CDX2-cre/ERT2)752Erf/0
Genetic
Background
involves: 129S4/SvJaeSor * C57BL/6J * SJL/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Map9tm1.1Bcgen mutation (0 available); any Map9 mutation (27 available)
Tg(CDX2-cre/ERT2)752Erf mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• 19% of mice injected with tamoxifen develop colonic dysplasia at 15 months post injection

homeostasis/metabolism
• mice treated with colonic carcinogen azoxymethane (AOM) show higher tumor incidence (100%) compared to treated wild-type mice (67%) and have an increase in tumor number and burden compared with controls

neoplasm
• mice treated with colonic carcinogen azoxymethane (AOM) show higher tumor incidence (100%) compared to treated wild-type mice (67%) and have an increase in tumor number and burden compared with controls





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
08/02/2024
MGI 6.24
The Jackson Laboratory